Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G49108TO
Summary
- GlyTouCan ID
-
G49108TO
- IUPAC Condensed
- GlcNAc(b1-
External Links
- GlyConnect structure
- GlyGen
- ChEBI
- PubChem Compound
- PubChem Substance
- The Human Metabolome Database
- CarbBank
-
- 9
- 3780
- 3968
- 4708
- 25653
- 28493
- 29021
- 29527
- 29549
- 31775
- 32028
- 32903
- 33539
- 36048
- 36270
- 37035
- 37525
- 37675
- 37677
- 37678
- 39452
- 39454
- 39456
- 39609
- 39611
- 39613
- 39614
- 40149
- 40150
- 40151
- 40355
- 40591
- 40600
- 42059
- 42207
- 42220
- 43184
- 43893
- 43925
- 43926
- 43931
- 43932
- 43941
- 44395
- 44396
- 44397
- 44549
- 46453
- 47268
- 47468
- 47537
- 47603
- 47796
- 48630
- 48812
- 48813
- 49006
- 49732
- 50589
- 50736
3D Structures
- GLYCAM
- DGlcpNAcb1-OH
G14843DJ
G68544GH
Organisms
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Rattus norvegicus (Norway rat) | |
| Homo sapiens (human) | |
| Drosophila melanogaster (fruit fly) | |
| Streptococcus pneumoniae |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
G49108TO
|
[beta]-S-pNP |
G00055MO
|
[beta]-S-pNP | |
| B3GALT2 | UDP-Gal |
G49108TO
|
Lemieux |
G00056MO
|
Lemieux | |
| B4GALT2 | UDP-Gal |
G49108TO
|
Benzyl-[beta] |
G00055MO
|
Benzyl-[beta] | |
| B4GALT1 | UDP-Gal |
G49108TO
|
R |
G00055MO
|
R | |
| B3GALT5 | UDP-Gal |
G49108TO
|
R |
G00056MO
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
G49108TO
|
[beta]-S-pNP |
G00055MO
|
[beta]-S-pNP | |
| B4GALT3 | UDP-Gal |
G49108TO
|
Benzyl-[beta] |
G00055MO
|
Benzyl-[beta] | |
| B4GALT4 | UDP-Gal |
G49108TO
|
[beta]-1-Benzl |
G00055MO
|
[beta]-1-Benzl | |
| B3GALT2 | UDP-Gal |
G49108TO
|
Lemieux |
G00056MO
|
Lemieux | |
| B4GALT4 | UDP-Gal |
G49108TO
|
[beta]-1-4-methyl-umbelliferyl |
G00055MO
|
[beta]-1-4-methyl-umbelliferyl |
Core Protein
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| O95819 | Mitogen-activated protein kinase kinase kinase kinase 4 | ||
| O95822 | Malonyl-CoA decarboxylase, mitochondrial | ||
| O95831 | Apoptosis-inducing factor 1, mitochondrial | ||
| O95835 | Serine/threonine-protein kinase LATS1 | ||
| O95838 | Glucagon-like peptide 2 receptor | ||
| O95861 | 3'(2'),5'-bisphosphate nucleotidase 1 | ||
| O95863 | Zinc finger protein SNAI1 | ||
| O95865 | Putative hydrolase DDAH2 | ||
| O95881 | Thioredoxin domain-containing protein 12 | ||
| P06454 | Prothymosin alpha |
GlycoEpitope
- Epitope ID
- EP0004
Pathway
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Xenopus tropicalis |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Danio rerio |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Homo sapiens |
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
- WURCS
- WURCS=2.0/1,1,0/[a2122h-1b_1-5_2*NCC/3=O]/1/
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 37087894 | Optimization of an α-aminonaphthylmethylphosphonic acid inhibitor of purple acid phosphatase using rational structure-based design approaches | Feder D | 2023 Jun 05 |
|
| 37270609 | Structural mapping of Nav1.7 antagonists | Wu Q | 2023 Jun 03 |
|
| 37334838 | An O-GlcNAc transferase pathogenic variant linked to intellectual disability affects pluripotent stem cell self-renewal | Omelková M | 2023 Jun 01 |
|
| 37260384 | Exploring the Catalytic Flexibility and Reversibility of Plant Glycosyltransferase HtUGT72AS1 for Glycodiversification of Phenolic Compounds | Wen C | 2023 Jun 01 |
|
| 37264005 | Structural interplay of anesthetics and paralytics on muscle nicotinic receptors | Goswami U | 2023 Jun 01 |
|
| 37328286 | A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer | Liu J | 2023 Jun |
|
| 37088134 | Nanobody inhibitors of Plexin-B1 identify allostery in plexin–semaphorin interactions and signaling | Cowan R | 2023 Jun |
|
| 36796536 | O-GlcNAcylation regulates phagocytosis by promoting Ezrin localization at the cell cortex | Yang S | 2023 Jul |
|
| 37494438 | Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor | Chia WN | 2023 Jul 28 |
|
| 37507370 | Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine | Guo S | 2023 Jul 28 |
|
PubAnnotation
